Mumbai: Sun Pharmaceutical Industries Limited has announced the appointment of Kirti Ganorkar as the company’s next Managing Director, effective September 1, 2025, succeeding the company’s current Managing Director, Dilip Shanghvi. In the new role, Ganorkar will take over the responsibility for the company’s entire business and functions  reporting to him.This appointment is subject to approval of the shareholders at the upcoming Annual General
Meeting. As Executive Chairman, Shanghvi will continue to chair the Board. He will focus on strengthening Sun Pharma’s specialty portfolio and provide insights towards shaping company’s long-term strategy, as per Sun Pharma’s release.Kirti Ganorkar has been heading India Business at Sun Pharma since June 2019. Under his leadership, the
company’s India Business has grown consistently, further increasing its market share. Previously, he has
held various leadership roles across business development, marketing, M&A, new product introduction,
project management, IP and litigation at Sun Pharma. He played a key role in driving Sun Pharma’s foray
into specialty by securing rights for innovative products such as Ilumya. Kirti led Sun Pharma’s entry into
Japan and laid initial groundwork for the company’s entry into Europe. He supported the U.S. business
with stewardship of several notable generic projects from concept to commercialisation. A chemical
engineer and MBA, Kirti joined Sun Pharma in 1996.
Kirti Ganorkar, Managing Director (Designate) of Sun Pharma stated, “It has been a profoundly rewarding
journey to participate in the company’s transformation into a leading global pharmaceutical enterprise.
Sun Pharma is at an exciting juncture with all its businesses well-positioned for growth. Building on the
strong foundation laid by Mr. Shanghvi and ably supported by our global leadership team, I’m confident
of continued success of the company.”
Dilip Shanghvi, Chairman & Managing Director of Sun Pharma said, “Kirti has consistently demonstrated
effective leadership managing diverse roles at Sun. I have a firm belief in his ability to lead the company
into its next phase of growth and extend my best wishes for his success. Kirti’s elevation showcases our
strong in-house talent pool, ensuring continuity of Sun’s core value systems.”